Insulin pumps

Topic Status Complete

Continuous subcutaneous insulin infusion (CSII or ‘insulin pumps’) for people with type 1 and gestational diabetes.

Summary

 

Health Technology Wales researchers searched for evidence on the clinical and cost effectiveness of continuous subcutaneous insulin infusion (CSII or ‘insulin pumps’) for people with type 1 and gestational diabetes. HTW’s Assessment Group reviewed this topic as part of a prioritisation exercise in February 2020 and concluded not to progress this topic further. This topic may be revisited in future and its suitability for fuller assessment reconsidered.

Topic Exploration Report

TER127 03.2020

TER
View PDF

Access our guidance

Our advice documents are free to download, but we would be grateful if you could help us improve our services by telling us why you are looking at our advice and how you intend to use it.
  • We may like to contact you by email to find out more about how you used the documents.

  • This field is for validation purposes and should be left unchanged.